vs
MEDIFAST INC（MED）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是MEDIFAST INC的1.0倍（$78.6M vs $75.1M），Repay Holdings Corp同比增速更快（0.4% vs -36.9%），Repay Holdings Corp自由现金流更多（$23.2M vs $-6.6M），过去两年Repay Holdings Corp的营收复合增速更高（-1.3% vs -34.4%）
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
MED vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.0倍
$75.1M
营收增速更快
RPAY
高出37.3%
-36.9%
自由现金流更多
RPAY
多$29.9M
$-6.6M
两年增速更快
RPAY
近两年复合增速
-34.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.1M | $78.6M |
| 净利润 | — | $-140.1M |
| 毛利率 | 69.4% | 74.2% |
| 营业利润率 | -10.4% | -182.2% |
| 净利率 | — | -178.3% |
| 营收同比 | -36.9% | 0.4% |
| 净利润同比 | — | -3304.1% |
| 每股收益（稀释后） | $-1.64 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEDRPAY
| Q4 25 | $75.1M | $78.6M | ||
| Q3 25 | $89.4M | $77.7M | ||
| Q2 25 | $105.6M | $75.6M | ||
| Q1 25 | $115.7M | $77.3M | ||
| Q4 24 | $119.0M | $78.3M | ||
| Q3 24 | $140.2M | $79.1M | ||
| Q2 24 | $168.6M | $74.9M | ||
| Q1 24 | $174.7M | $80.7M |
净利润MEDRPAY
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $-2.3M | $-6.4M | ||
| Q2 25 | $2.5M | $-102.3M | ||
| Q1 25 | $-772.0K | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $1.1M | $3.2M | ||
| Q2 24 | $-8.2M | $-4.1M | ||
| Q1 24 | $8.3M | $-5.2M |
毛利率MEDRPAY
| Q4 25 | 69.4% | 74.2% | ||
| Q3 25 | 69.5% | 74.4% | ||
| Q2 25 | 72.6% | 75.7% | ||
| Q1 25 | 72.8% | 75.9% | ||
| Q4 24 | 74.1% | 76.3% | ||
| Q3 24 | 75.4% | 77.8% | ||
| Q2 24 | 73.2% | 78.2% | ||
| Q1 24 | 72.8% | 76.2% |
营业利润率MEDRPAY
| Q4 25 | -10.4% | -182.2% | ||
| Q3 25 | -4.6% | -3.9% | ||
| Q2 25 | -1.0% | -138.7% | ||
| Q1 25 | -1.1% | -4.7% | ||
| Q4 24 | 0.6% | -1.5% | ||
| Q3 24 | 1.5% | -0.9% | ||
| Q2 24 | -4.7% | -4.6% | ||
| Q1 24 | 4.5% | -3.1% |
净利率MEDRPAY
| Q4 25 | — | -178.3% | ||
| Q3 25 | -2.5% | -8.3% | ||
| Q2 25 | 2.3% | -135.2% | ||
| Q1 25 | -0.7% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 0.8% | 4.1% | ||
| Q2 24 | -4.8% | -5.4% | ||
| Q1 24 | 4.8% | -6.5% |
每股收益（稀释后）MEDRPAY
| Q4 25 | $-1.64 | $-1.68 | ||
| Q3 25 | $-0.21 | $-0.08 | ||
| Q2 25 | $0.22 | $-1.15 | ||
| Q1 25 | $-0.07 | $-0.09 | ||
| Q4 24 | $0.08 | $-0.04 | ||
| Q3 24 | $0.10 | $0.03 | ||
| Q2 24 | $-0.75 | $-0.04 | ||
| Q1 24 | $0.76 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $198.9M | $484.4M |
| 总资产 | $248.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资MEDRPAY
| Q4 25 | $167.3M | $115.7M | ||
| Q3 25 | $173.5M | $95.7M | ||
| Q2 25 | $162.7M | $162.6M | ||
| Q1 25 | $164.6M | $165.5M | ||
| Q4 24 | $162.3M | $189.5M | ||
| Q3 24 | $170.0M | $168.7M | ||
| Q2 24 | $163.5M | $147.1M | ||
| Q1 24 | $156.4M | $128.3M |
总债务MEDRPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益MEDRPAY
| Q4 25 | $198.9M | $484.4M | ||
| Q3 25 | $214.7M | $616.9M | ||
| Q2 25 | $216.0M | $633.7M | ||
| Q1 25 | $211.0M | $755.7M | ||
| Q4 24 | $210.1M | $761.3M | ||
| Q3 24 | $207.3M | $754.7M | ||
| Q2 24 | $205.3M | $815.4M | ||
| Q1 24 | $211.0M | $813.8M |
总资产MEDRPAY
| Q4 25 | $248.0M | $1.2B | ||
| Q3 25 | $268.2M | $1.3B | ||
| Q2 25 | $269.3M | $1.4B | ||
| Q1 25 | $280.0M | $1.5B | ||
| Q4 24 | $284.2M | $1.6B | ||
| Q3 24 | $291.2M | $1.6B | ||
| Q2 24 | $293.5M | $1.5B | ||
| Q1 24 | $302.8M | $1.5B |
负债/权益比MEDRPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.6M | $23.2M |
| 自由现金流率自由现金流/营收 | -8.8% | 29.6% |
| 资本支出强度资本支出/营收 | 1.8% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.2M | $90.7M |
8季度趋势，按日历期对齐
经营现金流MEDRPAY
| Q4 25 | $-5.3M | $23.3M | ||
| Q3 25 | $12.1M | $32.2M | ||
| Q2 25 | $-3.4M | $33.1M | ||
| Q1 25 | $3.4M | $2.5M | ||
| Q4 24 | $-4.9M | $34.3M | ||
| Q3 24 | $9.1M | $60.1M | ||
| Q2 24 | $13.1M | $31.0M | ||
| Q1 24 | $7.3M | $24.8M |
自由现金流MEDRPAY
| Q4 25 | $-6.6M | $23.2M | ||
| Q3 25 | $10.8M | $32.1M | ||
| Q2 25 | $-4.8M | $33.0M | ||
| Q1 25 | $1.9M | $2.4M | ||
| Q4 24 | $-7.2M | $34.0M | ||
| Q3 24 | $7.7M | $59.8M | ||
| Q2 24 | $11.1M | $30.5M | ||
| Q1 24 | $5.4M | $24.7M |
自由现金流率MEDRPAY
| Q4 25 | -8.8% | 29.6% | ||
| Q3 25 | 12.0% | 41.3% | ||
| Q2 25 | -4.5% | 43.6% | ||
| Q1 25 | 1.6% | 3.0% | ||
| Q4 24 | -6.1% | 43.5% | ||
| Q3 24 | 5.5% | 75.6% | ||
| Q2 24 | 6.6% | 40.7% | ||
| Q1 24 | 3.1% | 30.6% |
资本支出强度MEDRPAY
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | 1.5% | 0.2% | ||
| Q2 25 | 1.3% | 0.1% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 1.9% | 0.3% | ||
| Q3 24 | 1.0% | 0.3% | ||
| Q2 24 | 1.1% | 0.6% | ||
| Q1 24 | 1.1% | 0.1% |
现金转化率MEDRPAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MED
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
